Week 12

Visualizing life

Two lectures by Professor Imperiali on the tools that make molecules in cells visible. Lecture 27 sets out the photophysics of fluorescence: a molecule absorbs light at a shorter, higher-energy wavelength and emits at a longer, lower-energy one. It then covers the DNA dyes biologists use, ethidium bromide, which intercalates between base pairs and is too toxic for living cells, and DAPI and Hoechst, which sit in the minor groove at AT-rich DNA and can be used on live cells. Antibodies come next as reagents: raised in rabbits or mice, polyclonal or monoclonal, and labeled with fluorophores to stain proteins such as actin and tubulin, but only in fixed, permeabilized cells because antibodies cannot cross the plasma membrane. Lecture 28 finishes DNA microarrays (a two-color comparison of cDNA from cancer and healthy cells, and what an array cannot detect) and then tells the story of green fluorescent protein, from Shimomura's jellyfish to Chalfie's expression in C. elegans and Tsien's engineering. GFP's chromophore forms by itself from a Ser-Tyr-Gly tripeptide inside a barrel, so a GFP fusion reports where a protein is in a living cell, and mutations at Tyr66 plus red proteins from corals extend the palette. Recitation 18 adds the firefly luciferase reaction and builds a GFP fusion to a membrane kinase.

Objectives

  • Distinguish chemiluminescence (luminol reacting with heme), bioluminescence (luciferase oxidizing luciferin with ATP, no light needed), and fluorescence (excitation by light), and explain why a luciferase reporter needs luciferin added
  • Explain why a fluorophore's emission wavelength is always longer (lower energy) than its excitation wavelength, and why a dye's fluorescence can depend on its environment, as when ethidium bromide brightens on binding DNA
  • Contrast ethidium bromide (an intercalator, toxic, fixed cells only) with DAPI and Hoechst (minor-groove binders at AT-rich DNA, supravital), and decide which dye can be used to follow DNA in living cells
  • Explain how fluorescently labeled antibodies raised in another species stain proteins such as actin and tubulin, and why this works only in fixed, permeabilized cells
  • Distinguish polyclonal antibodies (many epitopes on one antigen, collected from serum) from monoclonal antibodies (one epitope, made by hybridomas of spleen and myeloma cells)
  • Interpret a two-color microarray comparing labeled cDNA from cancer and healthy cells (red, green, yellow, and blank spots), and judge whether a given array can detect a particular defect, such as a point mutation or a problem that appears only at the protein level
  • Explain how GFP's Ser65-Tyr66-Gly67 tripeptide cyclizes and is oxidized by O₂ into the chromophore, why glycine allows the loop to form, and why the barrel's interior is needed for fluorescence
  • Explain how replacing Tyr66 gave blue and cyan variants, how extending the conjugated chromophore gives red proteins such as DsRed, and how changing alanines at the dimer interface made GFP monomeric
  • Design a GFP fusion that keeps the reading frame across the junction, and predict where it fluoresces and whether it works when a signal sequence, transmembrane domain, or catalytic domain is removed

Reading

Life 5.1Read for the cell theory and for how light and electron microscopes make cells visible, which also prepares for lecture 29. MIT assigned no reading for lecture 28, so the lectures and Recitation 18 are the source for fluorescent dyes, antibodies, microarrays, and GFP.

Lectures

27Visualizing life: dyes and stains47:32
28Visualizing life: fluorescent proteins41:22
1:28:54

Recitations

Recitation 18: GFP, luciferase, and microarrays

Reviews lectures 27 and 28: the discovery of GFP by Shimomura, Chalfie, and Tsien, the two-step firefly luciferase reaction and its use as a transcriptional reporter, and DNA microarrays for expression profiling. The problems revisit protein targeting and kinases, then design and test GFP fusions to a membrane kinase.

  1. (1a) Protein kinase X (PKX) has, from N to C terminus, a signal sequence, a transmembrane domain, and a kinase domain. Is it a cytosolic, organelle-specific, secreted, or membrane protein? Explain your choice.
  2. (1b) How does PKX activate its target protein? Explain.
  3. (1c-i) Once PKX has activated its target, how does a phosphatase return the target to its inactive state, and which amino acid residues can it act on?
  4. (1c-ii) How could a protease inactivate the target instead? Briefly explain the mechanism.
  5. (2) You fuse DNA encoding GFP to the DNA encoding the C terminus of PKX. The partial PKX cDNA near its C terminus is 5′-TCAAGAGGATCCCCGCGGTACCGAATTCCATGTTATAGCAAGCTCGGAATTAACCCTCAC-3′, with TAG as the stop codon; GGATCC is the site for enzyme Z and GAATTC the site for enzyme Y. The partial GFP cDNA near its N terminus is 5′-TCTAGAGGTACCGGGATCCGAATTCCC GTG CCA AGC GGC-3′, with its codons spaced and the same Z and Y sites. Enzyme Z cuts G/GATCC and enzyme Y cuts G/AATTC. Choose the restriction enzyme you would use to cut both genes before ligating them into a fusion gene, and explain why.
  6. (3) You make GFP-PKX fusions with GFP at the C terminus: wild type (signal sequence, transmembrane domain, kinase domain), variant 1 (transmembrane and kinase domains, no signal sequence), variant 2 (signal sequence and transmembrane domain, no kinase domain), variant 3 (signal sequence and kinase domain, no transmembrane domain), and variant 4 (kinase domain only). For each, say which part of the cell will fluoresce and whether the fusion is a functional protein, and explain.